New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Interview with Hair Transplant Surgeon Dr. B Limmer

Interview with Hair Transplant Surgeon Dr. B Limmer

 by Kevin RandsDr. Bobby Limmer speaks to HairlossTalk on Dr. Woods, ISHRS Conference, and Follicular Unit TransplantationWorld renowned hair transplant surgeon Dr. Bobby Limme
Dermatology December 04,2023
Interview with Hair Transplant Surgeon Dr. B Limmer

Interview with Hair Transplant Surgeon Dr. B Limmer

 by Kevin RandsDr. Bobby Limmer speaks to HairlossTalk on Dr. Woods, ISHRS Conference, and Follicular Unit TransplantationWorld renowned hair transplant surgeon Dr. Bobby Limme
Dermatology December 04,2023
Researchers discover two-pronged approach to stimulate STING antitumor activity

Researchers discover two-pronged approach to stimulate STING antitumor activity

byH. Lee Moffitt Cancer Center & Research InstituteSchematic of the STING agonist treatment schedule. Groups of STINGgt/gtmice were injected subcutaneously with 1.5 × 105B16-ISG
World medicine December 04,2023
Researchers discover two-pronged approach to stimulate STING antitumor activity

Researchers discover two-pronged approach to stimulate STING antitumor activity

byH. Lee Moffitt Cancer Center & Research InstituteSchematic of the STING agonist treatment schedule. Groups of STINGgt/gtmice were injected subcutaneously with 1.5 × 105B16-ISG
World medicine December 04,2023
'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

byLudwig Maximilian University of MunichBayesian tree vs. diagnostic tree. The statistical information displayed corresponds to the Bayesian information vs. diagnostic information presented in T
World medicine December 04,2023
'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

byLudwig Maximilian University of MunichBayesian tree vs. diagnostic tree. The statistical information displayed corresponds to the Bayesian information vs. diagnostic information presented in T
World medicine December 04,2023
An advanced pancreatic cancer model for developing personalized therapies

An advanced pancreatic cancer model for developing personalized therapies

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation have recently designed an advanced pancreatic tumor model which more accurately depicts
World medicine December 04,2023
An advanced pancreatic cancer model for developing personalized therapies

An advanced pancreatic cancer model for developing personalized therapies

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation have recently designed an advanced pancreatic tumor model which more accurately depicts
World medicine December 04,2023
Potential New Alopecia Areata Treatment

Potential New Alopecia Areata Treatment

 by Kevin RandsAlong-used anti-inflammatory prescription drug can help some people with alopecia areata or other forms of patchy baldness regrow their hair, according to a new report…Sulfasalazine is
World medicine December 04,2023
Potential New Alopecia Areata Treatment

Potential New Alopecia Areata Treatment

 by Kevin RandsAlong-used anti-inflammatory prescription drug can help some people with alopecia areata or other forms of patchy baldness regrow their hair, according to a new report…Sulfasalazine is
World medicine December 04,2023
Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected

Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected

byNagoya UniversityLocalized isocitrate dehydrogenase wild-type astrocytoma tumor before any surgery (left). Even after the removal of the tumor (middle), the patient had malignant recurrence (r
World medicine December 04,2023
Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected

Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected

byNagoya UniversityLocalized isocitrate dehydrogenase wild-type astrocytoma tumor before any surgery (left). Even after the removal of the tumor (middle), the patient had malignant recurrence (r
World medicine December 04,2023
Gel Prevents Chemotherapy Hair Loss

Gel Prevents Chemotherapy Hair Loss

 by Kevin Randsgrowing also prevented the baldness caused by chemotherapy treatment for cancer, at least in rats and mice, researchers said on Thursday.If it is shown to
Dermatology December 04,2023
Gel Prevents Chemotherapy Hair Loss

Gel Prevents Chemotherapy Hair Loss

 by Kevin Randsgrowing also prevented the baldness caused by chemotherapy treatment for cancer, at least in rats and mice, researchers said on Thursday.If it is shown to
Dermatology December 04,2023
Long-term results indicate that pathologic complete response is prognostic of outcomes for soft tissue sarcoma patients

Long-term results indicate that pathologic complete response is prognostic of outcomes for soft tissue sarcoma patients

by NRG OncologyCredit: CC0 Public DomainCombined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trial
World medicine December 04,2023
Long-term results indicate that pathologic complete response is prognostic of outcomes for soft tissue sarcoma patients

Long-term results indicate that pathologic complete response is prognostic of outcomes for soft tissue sarcoma patients

by NRG OncologyCredit: CC0 Public DomainCombined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trial
World medicine December 04,2023
'Super-enhancer' molecules super-charge pancreatic tumor growth

'Super-enhancer' molecules super-charge pancreatic tumor growth

bySalk InstitutePancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cancers are among the most aggressive, deadly tumor typ
World medicine December 04,2023
'Super-enhancer' molecules super-charge pancreatic tumor growth

'Super-enhancer' molecules super-charge pancreatic tumor growth

bySalk InstitutePancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic cancers are among the most aggressive, deadly tumor typ
World medicine December 04,2023
Risk for skin cancer higher for adults with atopic dermatitis

Risk for skin cancer higher for adults with atopic dermatitis

by Elana GotkineAdults with atopic dermatitis (AD) have an increased risk for developing melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC), with significantly higher risks seen f
World medicine December 04,2023
Risk for skin cancer higher for adults with atopic dermatitis

Risk for skin cancer higher for adults with atopic dermatitis

by Elana GotkineAdults with atopic dermatitis (AD) have an increased risk for developing melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC), with significantly higher risks seen f
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com